Incisive Genetics

Incisive Genetics is focused on creating an advanced non-viral delivery platform for genetic therapies, specifically utilizing lipid nanoparticles to encapsulate CRISPR components in a single step. This innovative approach addresses significant challenges in the effective delivery of gene-editing tools, ensuring both safety and efficacy. The company's pre-clinical pipeline targets genetic diseases affecting the nervous system and the eyes. Incisive Genetics is actively pursuing partnerships with pharmaceutical companies to enhance gene therapy development through its novel delivery system, aiming to facilitate convenient and safe drug delivery to patients.